The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Non-Opioid Pain Treatment Market By The End Of 2030?
The non-opioid pain treatment market size has seen significant growth in recent years. It is projected to increase from $55.31 billion in 2025 to $60.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.1%. Historically, this market expansion can be attributed to the rising prevalence of chronic pain conditions, growing awareness of opioid-related risks, the limited availability of non-opioid alternatives, an increase in orthopedic and musculoskeletal procedures, and the enhancing hospital and clinic infrastructure for pain management.
The non-opioid pain treatment market is projected to experience substantial expansion over the coming years. This market is set to reach a value of $84.36 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.7%. This anticipated growth during the forecast period is largely driven by factors such as the creation of advanced non-opioid therapeutics, the broadening use of digital health monitoring and telemedicine for pain, the increasing acceptance of combined therapies, heightened government efforts in pain management, and a surge in funding for individualized pain care and alternative approaches. Key developments expected in this period encompass the growing preference for non-opioid pain management solutions, an uptick in the utilization of medical cannabis and omega-3 fatty acid supplements, an increase in the availability of topical and injectable products for pain relief, the expansion of pain management services within hospitals and clinics, and the incorporation of non-pharmacological methods like acupuncture and TENS.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27366&type=smp
What Primary Drivers Are Shaping The Development Of The Non-Opioid Pain Treatment Market?
The increasing occurrence of sports-related injuries is projected to stimulate the growth of the non-opioid pain treatment market in the future. Sports-related injuries refer to physical harms incurred during or as a consequence of sports or exercise activities. This rising frequency of injuries stems from greater participation in high-intensity sports and recreational activities, which exposes athletes to an elevated risk of physical trauma. Non-opioid pain treatment offers utility for sports-related injuries by providing effective pain alleviation and reducing inflammation without the associated risks of opioid use, thereby facilitating faster recovery, improved function, and more secure long-term management. For instance, in October 2024, according to Howden Group Holdings Ltd, a UK-based insurance intermediary company, Europe’s top five leagues registered 4,123 injuries in the 2023-24 football season, marking a 4% increase compared to the previous season. Consequently, the growing incidence of sports-related injuries is driving the expansion of the non-opioid pain treatment market.
Which Segment Classifications Shape The Non-Opioid Pain Treatment Market?
The non-opioid pain treatment market covered in this report is segmented –
1) By Product: Medical Cannabis, Menthol-Containing, Omega 3 Fatty Acid-Containing, Botulinum Toxins, Capsaicin-Derived, Other Products
2) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (Nsaids), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids, Other Drug Classes
3) By Route Of Administration: Oral, Topical, Injectable, Other Route Of Administrations
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies
5) By Application: Orthopedic And Musculoskeletal Pain, Postoperative Pain, Cancer Pain, Neuropathic Pain, Other Applications
Subsegments:
1) By Medical Cannabis: Cannabidiol Based Products, Tetrahydrocannabinol Based Products, Combined Cannabinoid Products
2) By Menthol Containing: Topical Creams, Gels, Sprays
3) By Omega 3 Fatty Acid Containing: Fish Oil Derived Supplements, Algae Derived Supplements, Krill Oil Derived Supplements
4) By Botulinum Toxins: Onabotulinumtoxin A, Abobotulinumtoxin A, Incobotulinumtoxin A
5) By Capsaicin Derived: Low Concentration Creams, High Concentration Patches, Nasal Sprays
6) By Other Products: Magnesium Based Products, Acupuncture Devices, Transcutaneous Electrical Nerve Stimulation Devices
How Are Trends Impacting The Non-Opioid Pain Treatment Market?
Major companies in the non-opioid pain treatment market are concentrating on advancements in drug formulations, such as non-opioid oral treatment, to deliver effective pain relief and reduce the dangers connected to opioid use and addiction. Non-opioid oral treatment refers to orally administered pain-relieving medications that do not contain opioids and function via different mechanisms, like decreasing inflammation, adjusting nerve signals, or acting on specific receptors, to manage pain without the potential for addiction or respiratory depression commonly associated with opioids. For example, in July 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, introduced JOURNAVX, a pioneering non-opioid therapy offering effective relief for moderate-to-severe acute pain. This innovative non-opioid treatment operates through targeted modulation of pain pathways, provides a beneficial safety profile, and exhibits a rapid onset of action, facilitating strong pain control, reduced dependency potential, and enhanced patient well-being. It ensures precise pain management, decreases addiction risks, and supports quicker recovery and an improved quality of life for patients experiencing acute pain.
Which Companies Are Expanding Their Footprint In The Non-Opioid Pain Treatment Market?
Major companies operating in the non-opioid pain treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Limited, Vertex Pharmaceuticals Incorporated, SUN PHARMACEUTICAL INDUSTRIES LIMITED, Perrigo Company Public Limited Company, Dr. Reddy’s Laboratories, HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY, Pacira BioSciences Inc, Heron Therapeutics Inc, AFT Pharmaceuticals Limited, Vivozon Pharmaceutical Co. Ltd, Levicept Ltd, Algiax Pharmaceuticals GmbH, Latigo Biotherapeutics Inc, Hyloris Pharmaceuticals SA
Read the full non-opioid pain treatment market report here:
https://www.thebusinessresearchcompany.com/report/non-opioid-pain-treatment-global-market-report
How Does The Non-Opioid Pain Treatment Market Perform Across Major Global Regions?
North America was the largest region in the non-opioid pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-opioid pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Non-Opioid Pain Treatment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27366&type=smp
Browse Through More Reports Similar to the Global Non-Opioid Pain Treatment Market 2026, By The Business Research Company
Polyethylene Pipes Market Report 2026
https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report
Polyethylene Pipes Market Report 2026
https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report
Polyolefin Pipes Market Report 2026
https://www.thebusinessresearchcompany.com/report/polyolefin-pipes-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model